Showing results (151-160 of 268) with videos related to

Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1987
The pharmacology of intraperitoneally administered bleomycinS B Howell, M Schiefer, P A Andrews, et al.
Arthritis and Rheumatism|September 1, 1978
The costs of rheumatoid arthritis. A patient-oriented study of chronic disease costsR F Meenan, E H Yelin, C J Henke, et al.
Nursing Research|March 1, 1993
Correlates of fatigue in older adults with rheumatoid arthritisB L Belza, C J Henke, E H Yelin, et al.
Molecular Pharmacology|July 11, 1998
Sensitivity to cisplatin and platinum-containing compounds of Schizosaccharomyces pombe rad mutantsP Perego, F Zunino, N Carenini, et al.
Cancer Treatment Reports|April 1, 1985
Modulation of the activity of PALA by dipyridamoleT C Chan, B Young, M E King, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Synergistic interaction between cisplatin and tamoxifen delays the emergence of cisplatin resistance in head and neck cancer cell linesB Nakata, K D Albright, R M Barton, et al.
The American Journal of Medicine|January 1, 1985
Infectious peritonitis in patients receiving intraperitoneal chemotherapyR A Kaplan, M Markman, W E Lucas, et al.
Cancer Research|June 15, 1989
Comparison of the synergistic potentiation of etoposide, doxorubicin, and vinblastine cytotoxicity by dipyridamoleS B Howell, D Hom, R Sanga, et al.
Cancer Research|October 19, 2001
Hypoxia-induced enrichment and mutagenesis of cells that have lost DNA mismatch repairA Kondo, R Safaei, M Mishima, et al.
Cancer Research|January 1, 1988
Pharmacokinetics of intraperitoneally administered dipyridamole in cancer patientsT C Chan, G L Coppoc, S Zimm, et al.
Pageof 27